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Abstract
Background: Enterococci tend to be one of the leading causes of nosocomial infections, with E.
faecalis and E. faecium accounting up to 90% of the clinical isolates. Nevertheless, the incidence of
other species of enterococci from clinical sources shows an alarming increase with the properties
of intrinsic resistance to several antibiotics including beta-lactams and glycopeptides. Thus proper
identification of enterococci to species level is quintessential for management and prevention of
these bacteria in any healthcare facility. Hence this work was undertaken to study the prevalence
of unusual species of enterococci causing human infections, in a tertiary care hospital in South India.
Methods: The study was conducted in a tertiary care hospital in South India from July 2001 to June
2003. Isolates of enterococci were collected from various clinical specimens and speciated using
extensive phenotypic and physiological tests. Antimicrobial susceptibility testing were performed
and interpreted as per NCCLS guidelines. Whole cell protein (WCP) fingerprinting of enterococci
were done for species validation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and analyzed computationally.
Results: Our study showed the prevalence of unusual (non-faecalis and non-faecium enterococci)
and atypical (biochemical variant) species of enterococci as 19% (46 isolates) and 5% (12 isolates)
respectively. The 7 unusual species (46 isolates) isolated and confirmed by phenotypic
characterization includes: 15 E. gallinarum (6.2%), 10 E. avium (4.1%), 6 E. raffinosus (2.5%), 6 E. hirae
(2.5%), 4 E. mundtii (1.7%), 3 E. casseliflavus-including the two atypical isolates (1.2%) and 2 E. durans
(0.8%). The 12 atypical enterococcal species (5%) that showed aberrant sugar reactions in
conventional phenotyping were confirmed as E. faecalis, E. faecium and E. casseliflavus respectively
by WCP fingerprinting. The antimicrobial susceptibility testing depicted the emergence of high-level
aminoglycoside and beta-lactam resistance among different species apart from intrinsic vancomycin
resistance by some species, while all the species tested were susceptible for linezolid and
teicoplanin.
Conclusion: Our study reveals the emergence of multi-drug resistance among unusual species of
enterococci posing a serious therapeutic challenge. Precise identification of enterococci to species
level enables us to access the species-specific antimicrobial resistance characteristics, apart from
knowing the epidemiological pattern and their clinical significance in human infections.
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Background
Enterococci, generally regarded as normal flora of gas-
trointestinal and genitourinary tract of humans, have
emerged as the etiogen of several nosocomial as well com-
munity-acquired infections since last two decades. Glo-
bally, many studies have revealed that enterococci tend to
be one of the leading causes of several nosocomial infec-
tions, with the emergence and spread of multi drug resist-
ance among isolates [1-3]. Since the inception of separate
genus Enterococcus, there are 23 species of enterococci
with clinical significance to date [4], of which Enterococcus
faecalis and Enterococcus faecium accounts up to 90% of
clinical isolates belonging to this genus [1]. Nevertheless,
the incidence of other species of enterococci from clinical
sources shows an alarming increase with the properties of
intrinsic resistance to several antibiotics including beta-
lactams and glycopeptides [5,6]. But the incidence of non-
faecalis and non-faecium enterococci is underestimated
because of frequent misidentification. On several
instances only one phenotypic character differentiates one
species from another, and to further complicate some
strains of enterococci do not posses the exact phenotypic
character of the type strains, and there comes confusion
over their exact taxonomic status [7]. Thus proper identi-
fication of enterococci to species level is quintessential for
management and prevention of these bacteria in any
health care facility. Many studies focus on the two most
common species E. faecalis and E. faecium, and only few
reports or studies of non-faecalis and non-faecium entero-
cocci are prevalent [5,6]. Hence the aim of our study was
to check the prevalence of unusual and atypical species of
enterococci causing human infections, in a tertiary care
hospital in South India over a time period.
Methods
i. Bacterial isolates and conventional phenotypic 
characterization of enterococci
The study was conducted in a 900-bedded tertiary care
hospital at Pondicherry, South India from July 2001 to
June 2003. Isolates of enterococci were collected over the
time period from various clinical specimens such as
blood, urine, wound swabs and pus (surgical and non-
surgical), catheters, ascitic fluid, synovial fluid, by plating
them on 5% Sheep Blood agar and Mac-conkey agar, as
well on Bile esculin azide agar (Hi-media, Mumbai, India)
as per nature of the specimen. Extensive phenotypic and
physiological characterization was carried out by the con-
ventional tests devised by Facklam et al [3,8]. Carbohy-
drate fermentation tests were performed using 1% sugar
discs in Brain heart infusion (BHI) broth with Andrade's
indicator (Hi-media, Mumbai, India) as per manufac-
turer's instructions. The following sugars were tested for
fermentation by isolates using commercial discs: manni-
tol, sorbitol, inulin, arabinose, melibiose, sucrose, raffi-
nose, trehalose, lactose, glycerol, salicin, maltose,
adonitol, and xylose, while sorbose and ribose were
added to a final concentration of 1% to the broth base
directly after sterilization (due to non-availability of
discs). Group D antigen was detected using a commercial
latex agglutination kit (The Binding site limited, Birming-
ham, B29 6AT) as per manufacturer's™ instructions.
ii. Antimicrobial susceptibility testing
Antibiotic susceptibility testing of the clinical isolates
along with the quality control strains were performed
using BHI agar instead of Muller Hinton agar by disk dif-
fusion method (for the antibiotics: penicillin [10 units],
ampicillin [10 µg], gentamicin-high content [120 µg],
streptomycin-high content [300 µg], ciprofloxacin [5 µg],
nitrofurantoin-for urinary isolates only [300 µg], vanco-
mycin [30 µg], teicoplanin [30 µg] and linezolid [30 µg]),
standard agar dilution (for the antibiotics mentioned in
Table-1) and agar screening methods (for vancomycin
and high-level aminoglycoside resistance) and interpreted
as per NCCLS guidelines [9]. Production of β -lactamase
was determined by using nitrocefin discs (BBL Microsys-
tems) as per manufacturer's™ instructions.
iii. Molecular phenotyping of enterococci
Whole cell protein (WCP) analysis of the enterococcal iso-
lates, including atypical biochemical variants of entero-
cocci and the reference/type strains of enterococci (a kind
gift from Dr. Richard.R.Facklam, CDC, Atlanta, GA. USA)
were done using sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) as described previously
with minor modifications [10,11] for species identifica-
tion, as well confirmation of species identities of atypical
strains. Briefly, enterococcal test strains were grown for 18
hours at 37°C on Trypticase soy agar with 5% sheep
blood. The samples were prepared by removing the bacte-
rial growth from the surface of agar plate carefully with a
sterile disposable loop, and suspended in 5 ml of sterile
saline solution in order to obtain a turbidity equal to that
of No.8 MacFarland density standard, centrifuged, and
resuspended in 0.5 ml of an aqueous lysozyme solution
(10 mg/ml). The suspensions were incubated in a water
bath preset at 37°C for 2 hours. The WCP extracts were
obtained by mixing one part of whole cell extract to one
part of sample loading buffer, and boiled for 5 minutes
and separated by SDS-PAGE along with a broad range
molecular weight marker (New England Biolabs Inc.,) as
per standard procedure [11]. The SDS-PAGE was per-
formed using 5% stacking gel and 10% separating gel at a
constant current of 20 mA using a mini-gel electrophore-
sis system (Bangalore Genei, India) and stained with
Coomassie brilliant blue. Visual comparisons of the gels
were made, and documentation done using a Gel doc sys-
tem (Vilber loubert, France) for further analysis. The gel
images were analyzed and dendrogram constructed using
appropriate software (Bionumerics, version 2.5, AppliedBMC Infectious Diseases 2005, 5:14 http://www.biomedcentral.com/1471-2334/5/14
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Table 1: Analysis of MIC ranges of unusual species of enterococci.
Species tested 
(no.of.isolates
)
Antibiotic 
Tested
No. of isolates at specified MIC, in µg/mL Susca,%
248 1 6 3 2 ≥  64
E. avium ( 1 0 ) P e n . 999976 1 0
A m p . 966660 4 0
V a n . 420000 1 0 0
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A1 0 0
H L G m . N AN AN AN AN AN A 1 0
HLStr. NA NA NA NA NA NA 50
E. casseliflavus 
(3)
P e n . 000000 1 0 0
A m p . 000000 1 0 0
V a n . 330000 N A
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A6 6 . 6
H L G m . N AN AN AN AN AN A1 0 0
HLStr. NA NA NA NA NA NA 100
E. durans ( 2 ) P e n . 211100 5 0
A m p . 111100 5 0
V a n . 210000 1 0 0
T e . 100000 1 0 0
V a . S c r . N AN AN AN AN AN A 5 0
H L G m . N AN AN AN AN AN A 5 0
HLStr. NA NA NA NA NA NA 0
E. gallinarum 
(15)
P e n . 998888 4 6 . 6
A m p . 888876 4 6 . 6
V a n . 1 3 92000 N A
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A5 3 . 3
H L G m . N AN AN AN AN AN A4 6 . 6
HLStr. NA NA NA NA NA NA 66.6
E. hirae ( 6 ) P e n . 332200 6 6 . 6
A m p . 622200 6 6 . 6
V a n . 000000 1 0 0
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A1 0 0
H L G m . N AN AN AN AN AN A1 0 0
HLStr. NA NA NA NA NA NA 100
E. mundtii ( 4 ) P e n . 111000 1 0 0
A m p . 000000 1 0 0
V a n . 220000 1 0 0
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A 5 0
H L G m . N AN AN AN AN AN A1 0 0
HLStr. NA NA NA NA NA NA 50BMC Infectious Diseases 2005, 5:14 http://www.biomedcentral.com/1471-2334/5/14
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Maths, Kortrijik, Belgium) for validating the taxonomy of
the enterococcal species studied.
Results
Conventional and Molecular phenotyping of enterococci
We isolated a total of 242 enterococci during our 2-year
study period from different clinical samples. The bio-
chemical phenotyping results revealed 46 isolates (19%)
belonging to 7 different unusual species of enterococci
(excluding  E. faecalis and  E. faecium-data not shown)
which included 15 E. gallinarum (6.2%), 10 E. avium
(4.1%), 6 E. raffinosus (2.5%), 6 E. hirae (2.5%), 4 E. mun-
dtii  (1.7%), 3 E. casseliflavus (1.2%) and 2 E. durans
(0.8%). The distribution by site of isolation for the 46
unusual enterococcal species included 30 isolates- 12 E.
gallinarum, 6 E. avium, 3 each of E. hirae, E. casseliflavus
and E. raffinosus, 2 E. mundtii and 1 E. durans (65.2%)
from bloodstream, 6 isolates- 3 E. raffinosus, 2 E. avium
and 1 E. mundtii (13 %) from surgical and non-surgical
wound swabs, 10 isolates- 3 each of E. hirae and E. galli-
narum, 2 E. avium and 1 each of E. durans and E. mundtii
(21.8%) from miscellaneous sites, including muscle tis-
sues sent for anaerobic culture, catheter tips, peritoneal
fluid, ear swab and urine. Of the 46 persons from whom
unusual enterococci were obtained, 56.5% were males
and 43.5% were females including newborn/neonates.
The infections were polymicrobial in 6 (13%) of the 46
cases from which unusual enterococci were isolated,
including 2 (6.7%) of 30 bloodstream infections. The 12
atypical enterococcal strains (5%) showing aberrant sugar
reactions included 6 mannitol negative variant E. faecalis
like species, 1 arginine negative variant E. faecalis like spe-
cies, 3 mannitol negative variant E. faecium like species
and, 2 arginine negative variant E. casseliflavus like species.
The WCP analysis by SDS-PAGE confirmed the species
identities of seven different species. Atypical strains
showed a similar banding pattern like the reference strains
from CDC (E. faecalis SS-1273, E. faecium SS-1274, E. cas-
seliflavus  SS-1229) except for minor quantitative differ-
ences, with no qualitative difference. The computational
analysis of the WCP gel images of atypical strains were
performed by Dice coefficient, and the dendrogram con-
structed using unweighted pair group method using arith-
metic averages (UPGMA) as shown in Figure-1, and
validated their exact taxonomic status as E. faecalis, E. fae-
cium and E. casseliflavus respectively. The 2 (atypical) iso-
lates of arginine negative variant E. casseliflavus like species
after taxonomic validation were included as an unusual
species of enterococci accounting to 3 E. casseliflavus iso-
lated overall.
Antimicrobial susceptibility testing
The antimicrobial susceptibilities of the isolates given in
Table-1 depict the ranges of MICs for various antimicro-
bial agents tested by standard agar dilution, and agar
screening methods. The E. gallinarum and E. casseliflavus
isolates showed reduced susceptibility to lesser concentra-
tions of vancomycin ranging 2–8 µg/ml. Other species
were highly susceptible for vancomycin and teicoplanin
except one isolate of E. durans. High-level aminoglycoside
resistance for gentamicin and streptomycin was found
absent only in E. casseliflavus and E. hirae, while other spe-
cies exhibited variable susceptibilities ranging 0 – 66.7%
for either aminoglycoside tested. The disk diffusion test-
ing showed 100% susceptibility for linezolid and teico-
planin by all isolates tested, while E. casseliflavus and E.
mundtii  showed 100% susceptibility for penicillin and
ampicillin. Only 37% of unusual enterococcal isolates
were susceptible to ciprofloxacin, with resistance exhib-
ited by 9 E. avium (n = 10), 2 E. durans (n = 2), 11 E. gall-
inarum (n = 15), 2 E. hirae (n = 6), 2 E. mundtii (n = 4) and,
3 E. raffinosus (n = 6). Only E. casseliflavus (n = 3) exhib-
E. raffinosus 
(6)
P e n . 444444 3 3 . 3
A m p . 444440 3 3 . 3
V a n . 000000 1 0 0
T e . 000000 1 0 0
V a . S c r . N AN AN AN AN AN A1 0 0
H L G m . N AN AN AN AN AN A6 6 . 6
HLStr. NA NA NA NA NA NA 66.6
NOTE:
a Interpretations based on NCCLS guidelines,
NA-not applicable; Susc- Susceptiblity,
Pen-Penicillin; Amp-Ampicillin; Van-Vancomycin; Te-Teicoplanin,
Va. Scr- Vancomycin resistance (6 µg/mL) agar screening,
HLGm- High-level gentamicin resistance (500 µg/mL) agar screening,
HLStr- High-level streptomycin resistance (2000 µg/mL) agar screening,
Table 1: Analysis of MIC ranges of unusual species of enterococci. (Continued)BMC Infectious Diseases 2005, 5:14 http://www.biomedcentral.com/1471-2334/5/14
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Cluster analysis of atypical strains of Enterococci using Dice coefficient and UPGMA method (Bionumerics, Applied Maths,  Belgium) Figure 1
Cluster analysis of atypical strains of Enterococci using Dice coefficient and UPGMA method (Bionumerics, Applied Maths, Bel-
gium). Note : SS- Designation of CDC standard strains, E. porcinosus is currently designated as E. villorum, E. pseudoav.- E. pseu-
doavium; E. malodorat.- E. malodoratus, E. casselifla.- E. casseliflavus, MNV- Mannitol negative variant; ANV- Arginine negative 
variant.
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ited 100% susceptibility to ciprofloxacin. None of the 46
isolates was positive for β -lactamase, but resistance for β -
lactam agents were prevalent variably among different
species. The results of MICs for penicillin, ampicillin,
high-level gentamicin and high-level streptomycin resist-
ance were in accordance with the disk diffusion testing
results except for vancomycin. Disk diffusion testing
showed vancomycin resistance for 6 isolates (1 E. durans,
2  E. mundtii, 3 E. gallinarum), but the agar screening
method exhibited vancomycin resistance for 11 isolates (2
E. mundtii, 1 E. casseliflavus, 1 E. durans, 7 E. galli-
narum)(including 5 isolates-4 E. gallinarum and 1 E. cas-
seliflavus, which showed susceptibility to vancomycin by
the disk diffusion method).
Discussion
Our study reveals that the prevalence of unusual species of
enterococci as 19% in our clinical setup in South India.
Many studies and reviews show the prevalence of non-fae-
calis and non-faecium enterococci as 2–10% [3,6,12]. Pre-
vious studies from India have reported E. faecalis and E.
faecium as the only prevalent species [13-16], which may
not reflect the true incidence rate. From our perspective
the real incidence tends to be higher which in part can be
explained as, misidentification of species due to exhibi-
tion of aberrant sugar reactions by some enterococci or,
due to lack of application of the complete range of tests to
identify non-faecalis and non-faecium enterococci [7,17].
The prevalence rate (19%) of our study was partly in
accordance with another Indian study [18] showing
14.8% (excluding E. faecalis and E. faecium) prevalence of
unusual species of enterococci from catheterized patients
with urinary tract infections. E. mundtii and E. durans were
not reported in their study, whose prevalence was 1.7%
and 0.8% respectively in our study. E. gallinarum (6.2%)
and E. avium (4.1%) were the most commonly identified
species, which markedly differs in isolation rate (0.3–
1.2%) from other studies [6,19,20]. The incidence of
infections caused by unusual enterococcal species is of
serious concern, since 43.5% of the isolates were from
cases of septicemia without endocarditis. Apart from sep-
ticemia, the unusual species of enterococci were isolated
frequently from cases of urinary tract infections, surgical
and non-surgical wound infections and peritonitis. Most
of the patients with the bloodstream infections had a
peripheral or central catheter. Further, only 13% of ente-
rococcal infections were polymicrobial, with majority
from non-bloodstream isolates that underscores the clini-
cal significance of these unusual enterococcal species.
Although the unusual species of enterococci were isolated
at regular intervals throughout our study period, we could
find clustering of specific species during a specific time
period from specific units/wards. Interestingly, 10 among
the 15 isolates of E. gallinarum isolated during our study
period were from pediatrics unit, while 7 of the 10 isolates
exhibiting a similar antibiotype were isolated from the
same ward within a span of 2 months. The remaining 3 of
the 10 E. gallinarum were isolated from the same ward in
the preceding 3 months, one of which showed an antibi-
otype similar to the cluster of 7 isolates. The same was the
case of 3 E. casseliflavus isolated from the same pediatrics
unit within a span of 2 months in the preceding year. Most
of these (8 of 10 E. gallinarum, and all 3 E. casseliflavus)
isolates were from cases of septicemia. Although molecu-
lar epidemiological studies have not been done to com-
pare the genetic similarities of these isolates, the data
depicts the nosocomial spread of these species. WCP anal-
ysis by SDS-PAGE had been proven to assist in validating
the species identities as well, to identify strains that do not
exhibit phenotypic characteristics identical to the type
strains of each species [4,10,21]. We were able to validate
the authenticity of the unusual species, and the exact tax-
onomic status of the atypical phenotypic variant strains
identified by conventional biochemical testing as shown
in Figure-1, using WCP fingerprinting by SDS-PAGE.
Ciprofloxacin resistance was 63% among isolates (except-
ing E. casselifalvus) which proves that it may be successful
only in treating enterococcal urinary tract infections [1,9],
since most of our isolates were from bloodstream and
other related specimens. None of the isolates were β -lacta-
mase producer, but penicillin and ampicillin resistance
were exhibited by 54.3% and 45.7% isolates. We suggest
penicillin binding protein modification based resistance
for our isolates as a basis for β -lactam resistance, as
depicted previously [22,23], but markedly differs from
other Indian studies [15,24] showing up to 50% β -lacta-
mase associated resistance. The prevalence of high-level
gentamicin resistance (43.4%) and high-level streptomy-
cin (37%) among unusual enterococcal isolates from our
study partially correlates with studies from Japan [25] and
United States [12,26]. In our study, most strains with
high-level gentamicin resistance lacked high-level strepto-
mycin resistance, and vice versa, thus facilitating the com-
bination therapy (cell wall inhibitor plus
aminoglycoside) treatment options for serious enterococ-
cal bloodstream infections [1,9]. The prevalence of vanco-
mycin resistance was 24% by agar screening /agar dilution
method and 13% by disk diffusion. The difference may be
attributed to the intrinsic low level vancomycin resistance
(van C genotype), exhibited by 4 E. gallinarum and, 1 E.
casseliflavus isolates, which may go undetected by disk dif-
fusion testing [27]. Of serious concern was the low-level
vancomycin resistance exhibited by one E. durans and two
E. mundtii (MIC ≤  6 µg/ml). The genotypic basis of vanco-
mycin resistance for these 3 isolates yet to be studied, will
give us a definitive picture regarding its clinical signifi-
cance, since studies have reported the prevalence of van-
comycin resistance in these two species, and its
transferable nature from E. durans to E. faecium [28-30].BMC Infectious Diseases 2005, 5:14 http://www.biomedcentral.com/1471-2334/5/14
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Conclusion
Precise identification of enterococci to species level ena-
bles us, to access the species-specific antimicrobial resist-
ance characteristics, apart from knowing the
epidemiological pattern and their clinical significance in
human infections. The difficulty in detecting (intrinsic)
low-level vancomycin resistance by disk diffusion testing
[28] emphasizes the necessity for including agar screening
methods as per NCCLS guidelines in routine susceptibility
testing of all enterococci isolated from clinical specimens
[9]. Further as shown in our study, the increase in the rate
of prevalence of the unusual and atypical species and the
emergence of multidrug resistance among them, high-
lights the significance of rapid and accurate identification
of enterococci to the species level for initiating appropri-
ate therapeutic regimen, and reemphasizes the impor-
tance of the implementation of appropriate infection
control measures to limit the nosocomial spread of these
unusual species in any nosocomial setting.
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